SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-19-009176
Filing Date
2019-08-09
Accepted
2019-08-09 16:31:59
Documents
68
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tgtx-20190630.htm   iXBRL 10-Q 1811750
7 EXHIBIT 10.1 tgtx_ex101.htm EX-10.1 293858
8 EXHIBIT 10.2 tgtx_ex102.htm EX-10.2 338175
9 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 17714
10 EXHIBIT 31.2 exhibit31-2.htm EX-31.2 17705
11 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 6061
12 EXHIBIT 32.2 exhibit32-2.htm EX-32.2 6187
  Complete submission text file 0001654954-19-009176.txt   6442668

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE tgtx-20190630.xsd EX-101.SCH 36581
3 XBRL CALCULATION FILE tgtx-20190630_cal.xml EX-101.CAL 51892
4 XBRL DEFINITION FILE tgtx-20190630_def.xml EX-101.DEF 83546
5 XBRL LABEL FILE tgtx-20190630_lab.xml EX-101.LAB 434656
6 XBRL PRESENTATION FILE tgtx-20190630_pre.xml EX-101.PRE 227513
13 EXTRACTED XBRL INSTANCE DOCUMENT tgtx-20190630_htm.xml XML 812088
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32639 | Film No.: 191013371
SIC: 2834 Pharmaceutical Preparations